Telix Pharma To Acquire ITM In Deal Worth Up To $2.35 Bln
(RTTNews) - Telix Pharmaceuticals Ltd. (TLX,TLX.AX) announced that it signed an agreement to acquire privately held ITM Isotope Technologies Munich SE in a transaction valued at up to US$2.35 billion, strengthening its position in the global radiopharmaceutical and radioisotope m
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.